BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31997396)

  • 1. Membrane association of a model CD4
    Yunis J; Redwood AJ; Belz GT; Stevenson PG
    Immunol Cell Biol; 2020 Apr; 98(4):332-343. PubMed ID: 31997396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model.
    El-Gogo S; Staib C; Meyr M; Erfle V; Sutter G; Adler H
    Vaccine; 2007 May; 25(20):3934-45. PubMed ID: 17433507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Control of
    Stevenson PG
    Viral Immunol; 2020 Apr; 33(3):225-232. PubMed ID: 31334688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T cells specific for a model latency-associated antigen fail to control a gammaherpesvirus in vivo.
    Smith CM; Rosa GT; May JS; Bennett NJ; Mount AM; Belz GT; Stevenson PG
    Eur J Immunol; 2006 Dec; 36(12):3186-97. PubMed ID: 17109468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CD4
    Lawler C; Stevenson PG
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single CD8+ T cell epitope sets the long-term latent load of a murid herpesvirus.
    Marques S; Alenquer M; Stevenson PG; Simas JP
    PLoS Pathog; 2008 Oct; 4(10):e1000177. PubMed ID: 18846211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced functional capacity of CD8+ T cells expanded by post-exposure vaccination of gamma-herpesvirus-infected CD4-deficient mice.
    Liu H; Andreansky S; Diaz G; Hogg T; Doherty PC
    J Immunol; 2002 Apr; 168(7):3477-83. PubMed ID: 11907108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection.
    Sparks-Thissen RL; Braaten DC; Kreher S; Speck SH; Virgin HW
    J Virol; 2004 Jul; 78(13):6827-35. PubMed ID: 15194758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.
    MacDonald MR; Li XY; Stenberg RM; Campbell AE; Virgin HW
    J Virol; 1998 Jan; 72(1):442-51. PubMed ID: 9420244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with murid herpesvirus-4 glycoprotein B reduces viral lytic replication but does not induce detectable virion neutralization.
    May JS; Stevenson PG
    J Gen Virol; 2010 Oct; 91(Pt 10):2542-52. PubMed ID: 20519454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune control of mammalian gamma-herpesviruses: lessons from murid herpesvirus-4.
    Stevenson PG; Simas JP; Efstathiou S
    J Gen Virol; 2009 Oct; 90(Pt 10):2317-2330. PubMed ID: 19605591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining immune engagement thresholds for in vivo control of virus-driven lymphoproliferation.
    Godinho-Silva C; Marques S; Fontinha D; Veiga-Fernandes H; Stevenson PG; Simas JP
    PLoS Pathog; 2014 Jun; 10(6):e1004220. PubMed ID: 24967892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion of non-target antigen in vaccination favors generation of OVA specific CD4 memory T cells.
    MohanKrishnan A; Patel H; Bhurani V; Parmar R; Yadav N; Dave N; Rana S; Gupta S; Madariya J; Vyas P; Dalai SK
    Cell Immunol; 2019 Mar; 337():1-14. PubMed ID: 30773218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect CD4
    Xie W; Bruce K; Belz GT; Farrell HE; Stevenson PG
    J Virol; 2024 May; 98(5):e0049324. PubMed ID: 38578092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ T cell evasion mandates CD4+ T cell control of chronic gamma-herpesvirus infection.
    Tan CSE; Lawler C; Stevenson PG
    PLoS Pathog; 2017 Apr; 13(4):e1006311. PubMed ID: 28394921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
    Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
    Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An optimized CD8+ T-cell response controls productive and latent gammaherpesvirus infection.
    Braaten DC; Sparks-Thissen RL; Kreher S; Speck SH; Virgin HW
    J Virol; 2005 Feb; 79(4):2573-83. PubMed ID: 15681457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency.
    McClellan JS; Tibbetts SA; Gangappa S; Brett KA; Virgin HW
    J Virol; 2004 Jul; 78(13):6836-45. PubMed ID: 15194759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited protection against γ-herpesvirus infection by replication-deficient virus particles.
    Lawler C; Stevenson PG
    J Gen Virol; 2020 Apr; 101(4):420-425. PubMed ID: 31985394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques.
    Leskowitz R; Fogg MH; Zhou XY; Kaur A; Silveira EL; Villinger F; Lieberman PM; Wang F; Ertl HC
    J Virol; 2014 May; 88(9):4721-35. PubMed ID: 24522914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.